Patents by Inventor Saori Kanai

Saori Kanai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7745481
    Abstract: Certain cyclooxygenase-2 inhibitors are useful for the treatment and prevention of tumors and tumor-related disorders and cachexia.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: June 29, 2010
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Shinichi Kurakata, Masaharu Hanai, Saori Kanai, Tomio Kimura
  • Patent number: 6887893
    Abstract: Certain cyclooxygenase-2 inhibitors are useful for the treatment and prevention of tumors and tumor-related disorders and cachexia.
    Type: Grant
    Filed: December 16, 1998
    Date of Patent: May 3, 2005
    Assignee: Sankyo Company, Limited
    Inventors: Shinichi Kurakata, Masaharu Hanai, Saori Kanai, Tomio Kimura
  • Publication number: 20050014814
    Abstract: Certain cyclooxygenase-2 inhibitors are useful for the treatment and prevention of tumors and tumor-related disorders and cachexia.
    Type: Application
    Filed: August 13, 2004
    Publication date: January 20, 2005
    Applicant: SANKYO COMPANY, LIMITED
    Inventors: Shinichi Kurakata, Masaharu Hanai, Saori Kanai, Tomio Kimura
  • Publication number: 20050004109
    Abstract: Certain cyclooxygenase-2 inhibitors are useful for the treatment and prevention of tumors and tumor-related disorders and cachexia.
    Type: Application
    Filed: July 29, 2004
    Publication date: January 6, 2005
    Inventors: Shinichi Kurakata, Masaharu Hanai, Saori Kanai, Tomio Kimura
  • Patent number: 6511965
    Abstract: A compound of formula (I) below, which exhibits excellent macrophage activity inhibitory action, is useful for the treatment or prophylaxis of inflammatory disorders, autoimmune diseases or septicemia. In a preferred embodiment, R1 and R3 each represents a C1-C20 alkanoyl group which may optionally be substituted with one or more substituent groups selected from substituent group A, R2 and R4 each represents a C1-C20 alkyl group which may optionally be substituted with one or more substituent groups selected from substituent group A, R5 is a hydrogen atom, a halogen atom, a hydroxy group, or a C1-C6 alkoxy group, and substituent group A is a halogen atom, a hydroxy group, an oxo group, a C1-C20 alkoxy group, or a C1-C20 alkanoyloxy group.
    Type: Grant
    Filed: August 9, 2001
    Date of Patent: January 28, 2003
    Assignee: Sankyo Company, Limited
    Inventors: Yukiko Kazama, Masao Shiozaki, Shinichi Kurakata, Saori Kanai
  • Publication number: 20020161221
    Abstract: A compound of formula (I) below, which exhibits excellent macrophage activity inhibitory action, is useful for the treatment or prophylaxis of inflammatory disorders, autoimmune diseases or septicemia. In a preferred embodiment, R1 and R3 each represents a C1-C20 alkanoyl group which may optionally be substituted with one or more substituent groups selected from substituent group A, R2 and R4 each represents a C1-C20 alkyl group which may optionally be substituted with one or more substituent groups selected from substituent group A, R5 is a hydrogen atom, a halogen atom, a hydroxy group, or a C1-C6 alkoxy group, and substituent group A is a halogen atom, a hydroxy group, an oxo group, a C1-C20 alkoxy group, or a C1-C20 alkanoyloxy group.
    Type: Application
    Filed: August 9, 2001
    Publication date: October 31, 2002
    Applicant: SANKYO COMPANY, LIMITED
    Inventors: Yukiko Kazama, Masao Shiozaki, Shinichi Kurakata, Saori Kanai